Stay updated on Nivolumab Combinations in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.

Latest updates to the Nivolumab Combinations in Urothelial Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed in the page's revision history.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedLocations section updated with new trial sites across the US, Canada, Australia, and multiple other regions. Several previously listed locations were removed, altering the geographic coverage of study sites.SummaryDifference3%

- Check51 days agoChange DetectedAdded a 2025 publication by Tomita et al. on nivolumab plus gemcitabine-cisplatin in urothelial carcinoma. Removed the earlier ahead-of-print citation and updated the study record to Revision v3.3.2.SummaryDifference0.0%

- Check58 days agoChange DetectedThe Publications section text now states that publications are automatically filled from PubMed and may not be about the study, and the revision label updated to v3.3.1.SummaryDifference0.0%

- Check65 days agoChange DetectedRemoved a site-wide government funding status notice at the top of the page; the rest of the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page shows additions of new update dates (2025-10-24, 2026-02-19, 2025-10-08, 2025-10) and deletions of past update dates (2025-09-18, 2025-11-24, 2025-08-28, 2025-08). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab Combinations in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Urothelial Cancer Clinical Trial page.